We are live on ! Find out more
FL

Fort LP Portfolio holdings

AUM $39.6M
1-Year Est. Return 37.11%
This Fund
S&P 500
This Quarter Est. Return
+19.45%
1 Year Est. Return
+37.11%
3 Year Est. Return
+56.81%
5 Year Est. Return
+128.28%
10 Year Est. Return
+343.79%
AUM
$185M
AUM Growth
-$262M
Cap. Flow
-$322M
Cap. Flow %
-174.42%
Top 10 Hldgs %
7.26%
Holding
363
New
Increased
15
Reduced
254
Closed
94

Top Buys

Rank Stock Value
1
WST icon
West Pharmaceutical
WST
+$153K
2
EW icon
Edwards Lifesciences
EW
+$93.5K
3
VEEV icon
Veeva Systems
VEEV
+$88.6K
4
QLYS icon
Qualys
QLYS
+$84.1K
5
AMED
Amedisys
AMED
+$83.2K

Top Sells

Rank Stock Value
1
CABO icon
Cable One
CABO
+$2.47M
2
CTXS
Citrix Systems Inc
CTXS
+$2.45M
3
AAPL icon
Apple
AAPL
+$2.32M
4
TYL icon
Tyler Technologies
TYL
+$2.23M
5
CLX icon
Clorox
CLX
+$2.22M

Sector Composition

Rank Sector Weight
1 Technology 25.36%
2 Industrials 21.92%
3 Healthcare 17.4%
4 Consumer Staples 13.18%
5 Consumer Discretionary 9.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DGX icon
26
Quest Diagnostics
DGX
$23.3B
$1.09M 0.59%
9,613
-16,257
-63% -$1.72M
GRMN
27
Garmin
GRMN
$48.1B
$1.09M 0.59%
11,198
-19,413
-63% -$1.66M
EXPO icon
28
Exponent
EXPO
$3.05B
$1.09M 0.59%
13,455
-24,326
-64% -$1.75M
ROP icon
29
Roper Technologies
ROP
$36.6B
$1.09M 0.59%
2,800
-4,800
-63% -$1.72M
HRL icon
30
Hormel Foods
HRL
$14B
$1.08M 0.59%
22,479
-40,346
-64% -$1.93M
BMY icon
31
Bristol-Myers Squibb
BMY
$124B
$1.08M 0.58%
18,324
-29,344
-62% -$1.76M
INTU icon
32
Intuit
INTU
$79.6B
$1.07M 0.58%
3,621
-6,421
-64% -$1.76M
INFO
33
DELISTED
IHS Markit Ltd. Common Shares
INFO
$1.06M 0.57%
13,983
-25,010
-64% -$1.7M
BAH icon
34
Booz Allen Hamilton
BAH
$7.82B
$1.05M 0.57%
13,568
-24,642
-64% -$1.86M
V icon
35
Visa
V
$682B
$1.05M 0.57%
5,435
-9,593
-64% -$1.75M
ITW icon
36
Illinois Tool Works
ITW
$79.4B
$1.04M 0.57%
5,968
-10,436
-64% -$1.7M
VRSK icon
37
Verisk Analytics
VRSK
$26.3B
$1.04M 0.57%
6,132
-10,876
-64% -$1.72M
TRU icon
38
TransUnion
TRU
$15.4B
$1.04M 0.56%
11,982
-21,135
-64% -$1.69M
FFIV icon
39
F5
FFIV
$23.1B
$1.04M 0.56%
7,446
-12,322
-62% -$1.66M
CHD icon
40
Church & Dwight Co
CHD
$23.2B
$1.04M 0.56%
13,433
-22,983
-63% -$1.67M
SHW icon
41
Sherwin-Williams
SHW
$81.7B
$1.04M 0.56%
5,379
-9,876
-65% -$1.78M
ZTS icon
42
Zoetis
ZTS
$32.1B
$1.03M 0.56%
7,554
-13,677
-64% -$1.79M
ABT icon
43
Abbott
ABT
$175B
$1.03M 0.56%
11,306
-20,129
-64% -$1.82M
VRSN icon
44
VeriSign
VRSN
$25.3B
$1.03M 0.56%
4,994
-8,712
-64% -$1.81M
EXPD icon
45
Expeditors International
EXPD
$23.9B
$1.03M 0.56%
13,515
-23,096
-63% -$1.69M
ORCL icon
46
Oracle
ORCL
$364B
$1.02M 0.55%
18,498
-31,670
-63% -$1.68M
LSTR icon
47
Landstar System
LSTR
$7.18B
$1.02M 0.55%
9,070
-15,211
-63% -$1.63M
LDOS icon
48
Leidos
LDOS
$13.4B
$1.02M 0.55%
10,859
-20,191
-65% -$1.99M
WDFC icon
49
WD-40
WDFC
$3.31B
$1.02M 0.55%
5,124
-9,046
-64% -$1.64M
JNJ icon
50
Johnson & Johnson
JNJ
$609B
$1.01M 0.55%
7,221
-12,659
-64% -$1.84M

Similar funds

Fort LP's Q2 2020 Portfolio in Review

As of Q2 2020, Fort LP held 363 positions worth $185M, down 59% from $446M the previous quarter. Its ten largest holdings account for 7.3% of the portfolio.

Fort LP withdrew a net $322M in Q2 2020, closing 94 positions and reducing 254 holdings. Its most notable exit was Raytheon Company, an estimated $1.84M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Fort LP added an estimated $153K to West Pharmaceutical.

  • Fort LP added most to West Pharmaceutical in Q2 2020, an estimated $153K increase.
  • Fort LP's biggest Q2 2020 reduction was Cable One, cutting an estimated $2.47M.
  • Fort LP fully exited Raytheon Company in Q2 2020, selling an estimated $1.84M.
  • Fort LP's ten largest holdings make up 7.3% of its $185M portfolio in Q2 2020.
  • Fort LP opened 0 new positions and closed 94 in Q2 2020.
  • Fort LP's portfolio value fell 59% quarter-over-quarter to $185M.

Based on Fort LP's 13F filing for Q2 2020, filed 13 Aug 2020.